Omalizumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Omalizumab and local guidelines before prescribing.

Anti-IgE monoclonal antibody

Mechanism

Anti-IgE monoclonal antibody.

Uses

Severe allergic asthma, chronic spontaneous urticaria, nasal polyps.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Injection-site reactions, anaphylaxis (rare), headache.

Interactions

Few.

Contraindications and cautions

Anaphylaxis history

Monitoring

Asthma control

Pregnancy and breastfeeding

Limited data

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Observe after injection; check total IgE and weight for dosing.

More from the textbook: uses, cautions and other points
Where it is discussed in the book